Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity HEPATOLOGY INTERNATIONAL Burman, B. E., Kwo, P. Y., Kowdley, K. V. 2014; 8 (3): 352-364
View details for DOI 10.1007/s12072-014-9552-6
View details for Web of Science ID 000339939700008
View details for PubMedID 26202638